NCT00067548View on ClinicalTrials.gov

Study Evaluating EKB-569 in Advanced Non-Small Cell Lung Cancer

PHASE2CompletedINTERVENTIONAL

Enrollment

44

Participants

Timeline

Start Date

Not specified

Primary Completion Date

January 31, 2005

Study Completion Date

January 31, 2005

Conditions

Non-Small-Cell Lung CarcinomaCarcinoma, Non-Small Cell LungLung Neoplasms

Interventions

DRUG

EKB-569

All Listed Sponsors

lead

Wyeth is now a wholly owned subsidiary of Pfizer

INDUSTRY